Utilities Healthcare Sector

Oxford Biomedica

Market Cap: UK£339.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Verastem

Market Cap: US$456.6m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

PYC Therapeutics

Market Cap: AU$699.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Botanix Pharmaceuticals

Market Cap: AU$696.1m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

ORIC Pharmaceuticals

Market Cap: US$451.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Maze Therapeutics

Market Cap: US$450.2m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Sana Biotechnology

Market Cap: US$448.9m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

kneat.com

Market Cap: CA$613.8m

Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.

Cross Country Healthcare

Market Cap: US$443.2m

Provides talent management services for healthcare clients in the United States.

Tilray Brands

Market Cap: US$442.2m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Definitive Healthcare

Market Cap: US$441.9m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Sonida Senior Living

Market Cap: US$438.9m

Owns and operates senior housing communities in the United States.

PureTech Health

Market Cap: UK£324.3m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Claritev

Market Cap: US$436.5m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

Orthofix Medical

Market Cap: US$434.9m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

Bioventus

Market Cap: US$433.3m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

CytoDyn

Market Cap: US$423.9m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

SIGA Technologies

Market Cap: US$422.2m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Personalis

Market Cap: US$422.2m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Knight Therapeutics

Market Cap: CA$576.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Development Technologies

Market Cap: US$420.0m

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.

Paragon Care

Market Cap: AU$645.6m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

Vitalhub

Market Cap: CA$566.8m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

Atai Life Sciences

Market Cap: US$412.7m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Surmodics

Market Cap: US$410.4m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

Oruka Therapeutics

Market Cap: US$410.0m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

MeiraGTx Holdings

Market Cap: US$409.9m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Autolus Therapeutics

Market Cap: US$409.9m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Septerna

Market Cap: US$409.5m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Sage Therapeutics

Market Cap: US$408.9m

A biopharmaceutical company, develops and commercializes brain health medicines.

Senseonics Holdings

Market Cap: US$408.3m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

COMPASS Pathways

Market Cap: US$407.9m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

MBX Biosciences

Market Cap: US$406.1m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Precigen

Market Cap: US$404.4m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Tectonic Therapeutic

Market Cap: US$404.3m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Zhengye Biotechnology Holding

Market Cap: US$404.2m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.